Erzincan Binali Yıldırım ÜniversitesiErzincan Binali Yıldırım ÜniversitesiAçık Erişim Arşivi · RDL Open

Changes in antimicrobial resistance and outcomes of health care–associated infections

ArticleAçık Erişim

Özet

To describe the change in the epidemiology of health care–associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to 25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018. Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus methicillin, resistance increased from 31 to 41%. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Anahtar Kelimeler

associated infectionsBlood stream infectionsColistin resistanceHealth careAnti-Bacterial AgentsAntifungal AgentsBacteremiaBacteriaBacterial InfectionsCandidaCross InfectionDrug Resistance, BacterialFungemiaHumansMycosesRetrospective Studiescarbapenemcolistinmeticillinquinolonevancomycinantifungal agentantiinfective agentmycosisAcinetobacteradultantibiotic resistanceArticlebloodstream infectioncandidiasis
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13021Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s10096-020-04140-yYayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAydın, Mehtap
dc.contributor.authorAzak, Emel
dc.contributor.authorBilgin, Hüseyin
dc.contributor.authorMenekse, Sirin
dc.contributor.authorAsan, Ali
dc.contributor.authorMert, Habibe Tülin Elmaslar
dc.contributor.authorYulugkural, Zerrin
dc.contributor.authorAltunal, Lutfiye Nilsun
dc.contributor.authorHatipoğlu, Çiğdem Ataman
dc.contributor.authorTuncer Ertem, Gunay
dc.contributor.authorAltunok, Elif Sargın
dc.contributor.authorDemirkaya, Melike Hamiyet
dc.contributor.authorÇeviker, Sevil Alkan
dc.contributor.authorAkgul, Fethiye
dc.contributor.authorMemis, Zeynep
dc.contributor.authorKonya, Petek
dc.contributor.authorAzap, Alpay
dc.contributor.authorAydin, Gule
dc.contributor.authorKorkmaz, Derya
dc.contributor.authorKarakoç, Zehra Çagla
dc.contributor.authorYapar, Derya
dc.contributor.authorKarakecili, Faruk
dc.contributor.authorGunal, Ozgur
dc.contributor.authorKeske, Siran
dc.contributor.authorKapmaz, Mahir
dc.contributor.authorKader, Cigdem
dc.contributor.authorDemirel, Aslıhan
dc.contributor.authorErgönül, Önder
dc.date.accessioned2026-10-18T20:27:52.056867677Z
dc.date.available2026-10-18T20:27:52.056867677Z
dc.date.issued2021
dc.description.abstractTo describe the change in the epidemiology of health care–associated infections (HAI), resistance and predictors of fatality we conducted a nationwide study in 24 hospitals between 2015 and 2018. The 30-day fatality rate was 22% in 2015 and increased to 25% in 2018. In BSI, a significant increasing trend was observed for Candida and Enterococcus. The highest rate of 30-day fatality was detected among the patients with pneumonia (32%). In pneumonia, Pseudomonas infections increased in 2018. Colistin resistance increased and significantly associated with 30-day fatality in Pseudomonas infections. Among S. aureus methicillin, resistance increased from 31 to 41%. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
dc.identifier.doi10.1007/s10096-020-04140-y
dc.identifier.endpage1742
dc.identifier.issn0934-9723
dc.identifier.issue8
dc.identifier.pmid33586014
dc.identifier.scopus2-s2.0-85101454721
dc.identifier.startpage1737
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13021
dc.identifier.volume40
dc.language.isoen
dc.publisherSpringer Science and Business Media Deutschland GmbH
dc.relation.ispartofEuropean Journal of Clinical Microbiology and Infectious Diseases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectassociated infections
dc.subjectBlood stream infections
dc.subjectColistin resistance
dc.subjectHealth care
dc.subjectAnti-Bacterial Agents
dc.subjectAntifungal Agents
dc.subjectBacteremia
dc.subjectBacteria
dc.subjectBacterial Infections
dc.subjectCandida
dc.subjectCross Infection
dc.subjectDrug Resistance, Bacterial
dc.subjectFungemia
dc.subjectHumans
dc.subjectMycoses
dc.subjectRetrospective Studies
dc.subjectcarbapenem
dc.subjectcolistin
dc.subjectmeticillin
dc.subjectquinolone
dc.subjectvancomycin
dc.subjectantifungal agent
dc.subjectantiinfective agent
dc.subjectmycosis
dc.subjectAcinetobacter
dc.subjectadult
dc.subjectantibiotic resistance
dc.subjectArticle
dc.subjectbloodstream infection
dc.subjectcandidiasis
dc.titleChanges in antimicrobial resistance and outcomes of health care–associated infections
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus28
rdl.departmentSchool of Medicine, Department of Infectious Diseases and Clinical Microbiology, Erzincan Binali Yıldırım University, Erzincan, Turkey.
rdl.oa.statusgreen
rdl.source.indexSCOPUS
rdl.source.indexPUBMED